{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:40:50Z","timestamp":1768887650160,"version":"3.49.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.jinf.2006.03.003","type":"journal-article","created":{"date-parts":[[2006,5,7]],"date-time":"2006-05-07T07:12:53Z","timestamp":1146985973000},"page":"337-349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":245,"title":["Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis"],"prefix":"10.1016","volume":"53","author":[{"given":"David W.","family":"Denning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieren A.","family":"Marr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendi M.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Facklam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Voravit","family":"Ratanatharathorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita L.","family":"Seibel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Anne H.","family":"van Burik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald N.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2006.03.003_bib1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/jhin.2002.1258","article-title":"Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area","volume":"51","author":"Cornet","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jinf.2006.03.003_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0609.2004.00273.x","article-title":"Invasive fungal infections in autologous stem cell transplant recipients: a nation-wide study of 1188 transplanted patients","volume":"73","author":"Jantunen","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jinf.2006.03.003_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/bbmt.2002.v8.pm12374456","article-title":"Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study","volume":"8","author":"Junghanss","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2006.03.003_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1083-8791(03)00100-9","article-title":"Nonmyeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants","volume":"9","author":"Daly","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jinf.2006.03.003_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0891-5520(02)00035-1","article-title":"Aspergillosis. Pathogenesis, clinical manifestations, and therapy","volume":"16","author":"Marr","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jinf.2006.03.003_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1703332","article-title":"Late onset of invasive Aspergillus infection in bone marrow transplant patients at a university hospital","volume":"29","author":"Grow","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jinf.2006.03.003_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1053-2498(02)00477-1","article-title":"Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management","volume":"22","author":"Singh","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jinf.2006.03.003_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x","article-title":"The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants","volume":"4","author":"Minari","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib9","first-page":"897","article-title":"Aspergillosis in liver transplant recipients: successful treatment and improved survival using a multistep approach","volume":"95","author":"Duchini","year":"2002","journal-title":"South Med J"},{"key":"10.1016\/j.jinf.2006.03.003_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s15010-002-2033-1","article-title":"Invasive aspergillosis in Italian AIDS patients","volume":"30","author":"Libanore","year":"2002","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2006.03.003_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00134-003-2008-4","article-title":"A 7-year study of severe hospital-acquired pneumonia requiring ICU admission","volume":"29","author":"Valles","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jinf.2006.03.003_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2006.03.003_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1179\/joc.2003.15.1.71","article-title":"Disseminated aspergillosis in intensive care unit patients: an autopsy study","volume":"15","author":"Dimopoulos","year":"2003","journal-title":"J Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib14","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1378\/chest.123.2.488","article-title":"Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response","volume":"123","author":"Agusti","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jinf.2006.03.003_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.10392","article-title":"Infliximab for steroid-refractory acute GVHD: a case series","volume":"74","author":"Jacobsohn","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jinf.2006.03.003_bib16","first-page":"1278","article-title":"Death of a SARS case from secondary Aspergillus infection","volume":"117","author":"Wang","year":"2004","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jinf.2006.03.003_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/clinids\/23.3.608","article-title":"Therapeutic outcome in invasive aspergillosis","volume":"23","author":"Denning","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jinf.2006.03.003_bib19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2006.03.003_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14787210.2.3.345","article-title":"Micafungin: a therapeutic review","volume":"2","author":"Higashiyama","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2006.03.003_bib22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/AAC.44.3.614-618.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis","volume":"44","author":"Ikeda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.44.3.619-621.2000","article-title":"Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis","volume":"44","author":"Matsumoto","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkg185","article-title":"Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B","volume":"51","author":"Warn","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib25","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1469-0691.2004.00958.x","article-title":"Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis","volume":"10","author":"Chandrasekar","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2006.03.003_bib26","series-title":"Program and abstracts of the 39th interscience conference on antimicrobial agents and chemotherapy (San Francisco)","article-title":"Drug interaction in vitro between a polyene (AmBisome: AmBi) and an echinocandin (FK463:FK) vs Aspergillus species","author":"Stevens","year":"1999"},{"key":"10.1016\/j.jinf.2006.03.003_bib27","series-title":"Program and abstracts of the 40th interscience conference on antimicrobial agents and chemotherapy (Toronto)","article-title":"Synergistic effects of combination of FK463 with amphotericin B: enhanced efficacy in murine model of invasive pulmonary aspergillosis","author":"Kohno","year":"2000"},{"key":"10.1016\/j.jinf.2006.03.003_bib28","series-title":"Program and abstracts of the 40th interscience conference on antimicrobial agents and chemotherapy (Toronto)","article-title":"Pathological findings in a murine pulmonary aspergillosis model: treatment with FK463, amphotericin B and a combination of FK463 and amphotericin B","author":"Nakajima","year":"2000"},{"key":"10.1016\/j.jinf.2006.03.003_bib29","series-title":"Program and abstracts of the 39th interscience conference on antimicrobial agents and chemotherapy (San Francisco)","article-title":"Combination antifungal therapy with FK463 plus amphotericin B in treatment of experimental pulmonary aspergillosis","author":"Petraitis","year":"1999"},{"key":"10.1016\/j.jinf.2006.03.003_bib30","series-title":"Program and abstracts of the 41st interscience conference on antimicrobial agents and chemotherapy (Chicago)","article-title":"Assessment of maximum tolerated dose (MTD) of FK463 in cancer patients undergoing haematopoetic stem cell transplantation","author":"Powles","year":"2001"},{"key":"10.1016\/j.jinf.2006.03.003_bib31","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2036.2004.02083.x","article-title":"Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent","volume":"20","author":"Pettengell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2006.03.003_bib32","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","article-title":"Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant","volume":"49","author":"Hiemenz","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/00365540410020406","article-title":"A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan","volume":"36","author":"Kohno","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib34","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/423381","article-title":"Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy","volume":"39","author":"Maertens","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1200\/JCO.2001.19.1.253","article-title":"Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia","volume":"19","author":"Caillot","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jinf.2006.03.003_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","article-title":"NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis","volume":"97","author":"Denning","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.jinf.2006.03.003_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1086\/341401","article-title":"A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients","volume":"35","author":"Bowden","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib38","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2006.03.003_bib39","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1086\/324620","article-title":"Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis","volume":"34","author":"Denning","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.jinf.2006.03.003_bib40","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1086\/376524","article-title":"Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001","volume":"37","author":"Steinbach","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/clinids\/12.6.1147","article-title":"Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases","volume":"12","author":"Denning","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib43","series-title":"American Society of Hematology 44th annual meeting program and abstracts (Philadelphia)","article-title":"Micafungin in combination with systemic antifungal agents in the treatment of refractory aspergillosis (RA) in bone marrow transplant (BMT) patients","author":"Ratanatharathorn","year":"2002"},{"key":"10.1016\/j.jinf.2006.03.003_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cncr.11479","article-title":"Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies","volume":"98","author":"Kontoyiannis","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jinf.2006.03.003_bib45","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.micinf.2003.12.010","article-title":"Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus","volume":"6","author":"Choi","year":"2004","journal-title":"Microbes Infect"},{"key":"10.1016\/j.jinf.2006.03.003_bib46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/jac\/dkg425","article-title":"Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin","volume":"52","author":"Graybill","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib47","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1086\/375420","article-title":"Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin","volume":"187","author":"Petraitis","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib48","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/AAC.45.12.3310-3321.2001","article-title":"Synergy, pharmacodynamics, and time-sequenced ultrastructural changes of the interaction between nikkomycin Z and the echinocandin FK463 against Aspergillus fumigatus","volume":"45","author":"Chiou","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2006.03.003_bib49","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2003-02-0456","article-title":"Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jinf.2006.03.003_bib50","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","article-title":"A randomized, double-blind, parallel-group, dose\u2013response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients","volume":"39","author":"de Wet","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib51","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-2036.2005.02427.x","article-title":"A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis","volume":"21","author":"de Wet","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2006.03.003_bib52","series-title":"Program and abstracts of the 45th interscience conference on antimicrobial agents and chemotherapy (Washington, DC)","article-title":"Alternative day dosing of micafungin in the treatment of esophageal candidiasis","author":"Buell","year":"2005"},{"key":"10.1016\/j.jinf.2006.03.003_bib53","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s10096-005-0024-8","article-title":"International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia","volume":"24","author":"Ostrosky-Zeichner","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2006.03.003_bib54","series-title":"Program and abstracts of the 45th interscience conference on antimicrobial agents and chemotherapy (Washington, DC)","article-title":"Comparison of micafungin and liposomal amphotericin B for invasive candidiasis","author":"Ruhnke","year":"2005"},{"key":"10.1016\/j.jinf.2006.03.003_bib55","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/422312","article-title":"Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation","volume":"39","author":"van Burik","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445306000879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445306000879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:30:11Z","timestamp":1758987011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445306000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0163445306000879"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2006.03.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2006.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}